Second $20m loan for StemCells Inc alongside Capricor's first under California stem cell programme

The California Institute of Regenerative Medicine (CIRM) has approved its second round of "disease team" awards, which included two separate $20 million loans to cardiac stem cell specialist Capricor and StemCells Inc, which won a second loan to develop its purified human neural stem cells (HuCNS-SC).

The California Institute of Regenerative Medicine (CIRM) has approved its second round of "disease team" awards, which included two separate $20 million loans to cardiac stem cell specialist Capricor and StemCells Inc, which won a second loan to develop its purified human neural stem cells (HuCNS-SC).

The three loans to two commercial enterprises from CIRM's disease team programme represent a small step toward the agency's goal...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Cardiovascular

More from Therapeutic Category